Investor Webinar
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your VAL notes
ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, is pleased to invite existing and prospective shareholders to join Valirx CEO Dr Mark Eccleston for an interactive presentation and Q&A session on Monday, 21st October 2024 at 1pm where he will outline his vision and future direction for the Company.
The event will require prior registration, with registration links and full details available on the Company's website on https://www.valirx.com/contact.
The webinar will be available to view on demand through our website after the event.
The Directors of the Company take responsibility for this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.